# Chemed Corp: Form 10-K for the period ended Dec 31, 2010

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-K
- Filed: 2011-02-28
- Accepted by EDGAR: Feb 28, 2011, 20:20 ET
- Period: 2010-12-31
- Accession: 0000950123-11-019686
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000095012311019686/l41914e10vk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000095012311019686/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2010-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2010-01-01 to 2010-12-31 | $1.28bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months, 2010-01-01 to 2010-12-31 | $906.0m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 12 months, 2010-01-01 to 2010-12-31 | $202.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2010-01-01 to 2010-12-31 | $143.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2010-01-01 to 2010-12-31 | $12.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2010-01-01 to 2010-12-31 | $52.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2010-01-01 to 2010-12-31 | $81.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2010-01-01 to 2010-12-31 | $3.55 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2010-01-01 to 2010-12-31 | $3.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2010-01-01 to 2010-12-31 | 23,031,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2010-01-01 to 2010-12-31 | $86.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2010-01-01 to 2010-12-31 | $25.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2010-01-01 to 2010-12-31 | $11.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2010-01-01 to 2010-12-31 | $104.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2010-12-31 | $49.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2010-12-31 | $196.8m | us-gaap:AssetsCurrent |
| Total assets | at 2010-12-31 | $830.2m | us-gaap:Assets |
| Current liabilities | at 2010-12-31 | $149.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2010-12-31 | $368.1m | us-gaap:Liabilities |
| Long-term debt | at 2010-12-31 | $159.2m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2010-12-31 | $462.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000095012311019686/l41914e10vk.htm

Filed Feb 28, 2011.
Source: SEC EDGAR, the filing index for accession 0000950123-11-019686. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
